{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T01:51:50Z","timestamp":1775267510001,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.humpath.2012.10.009","type":"journal-article","created":{"date-parts":[[2013,1,17]],"date-time":"2013-01-17T17:46:34Z","timestamp":1358444794000},"page":"1241-1250","source":"Crossref","is-referenced-by-count":57,"title":["Expression of mammaglobin and gross cystic disease fluid protein-15 in breast carcinomas"],"prefix":"10.1016","volume":"44","author":[{"given":"Ming-Hua","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Hua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-Bi","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia Y.S.","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siu-Ki","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mu-Min","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary M.","family":"Tse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2012.10.009_bb0005","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0002-9378(80)90007-1","article-title":"Analysis of amniotic fluid, maternal plasma, and cord blood for a human breast gross cystic disease fluid protein","volume":"138","author":"Haagensen","year":"1980","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.humpath.2012.10.009_bb0010","doi-asserted-by":"crossref","first-page":"6169","DOI":"10.1021\/bi034038a","article-title":"Structural study of GCDFP-15\/gp17 in disease versus physiological conditions using a proteomic approach","volume":"42","author":"Caputo","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.humpath.2012.10.009_bb0015","first-page":"105","article-title":"Immunohistochemistry of a gross cystic disease fluid protein (GCDFP-15) of the breast. A marker of apocrine epithelium and breast carcinomas with apocrine features","volume":"110","author":"Mazoujian","year":"1983","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2012.10.009_bb0020","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1309\/TDP92PQLDE2HLEET","article-title":"Mammaglobin vs GCDFP-15: an immunohistologic validation survey for sensitivity and specificity","volume":"127","author":"Bhargava","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2012.10.009_bb0025","first-page":"1221","article-title":"Co-expression and prognostic value of gross cystic disease fluid protein 15 and mammaglobin in primary breast cancer","volume":"22","author":"Fritzsche","year":"2007","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.humpath.2012.10.009_bb0030","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1002\/1097-0142(19890601)63:11<2156::AID-CNCR2820631115>3.0.CO;2-B","article-title":"Haagensen CD. Expression of GCDFP-15 in breast carcinomas. Relationship to pathologic and clinical factors","volume":"63","author":"Mazoujian","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2012.10.009_bb0035","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0046-8177(89)90137-8","article-title":"Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin","volume":"20","author":"Wick","year":"1989","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2012.10.009_bb0040","first-page":"860","article-title":"Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer","volume":"56","author":"Watson","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2012.10.009_bb0045","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/modpathol.3800731","article-title":"Breast-specific expression of MGB1\/mammaglobin: an examination of 480 tumors from various organs and clinicopathological analysis of MGB1-positive breast cancers","volume":"20","author":"Sasaki","year":"2007","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2012.10.009_bb0050","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1471-2407-6-88","article-title":"Expression analysis of mammaglobin A (SCGB2A2) and lipophilin B (SCGB1D2) in more than 300 human tumors and matching normal tissues reveals their co-expression in gynecologic malignancies","volume":"6","author":"Zafrakas","year":"2006","journal-title":"BMC Cancer"},{"key":"10.1016\/j.humpath.2012.10.009_bb0055","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1309\/AJCPMFR6OA8ICHNH","article-title":"Relationship between molecular subtype of invasive breast carcinoma and expression of gross cystic disease fluid protein 15 and mammaglobin","volume":"135","author":"Lewis","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2012.10.009_bb0060","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2559.1991.tb00229.x","article-title":"Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up","volume":"19","author":"Elston","year":"1991","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2012.10.009_bb0065","series-title":"World Health Organisation classification of tumors of the breast","year":"2012"},{"key":"10.1016\/j.humpath.2012.10.009_bb0070","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1200\/JCO.2009.25.6529","article-title":"American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer","volume":"28","author":"Hammond","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2012.10.009_bb0075","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1200\/JCO.2006.09.2775","article-title":"American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer","volume":"25","author":"Wolff","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2012.10.009_bb0080","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/annonc\/mdr304","article-title":"Strategies for subtypes\u2014dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011","volume":"22","author":"Goldhirsch","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.humpath.2012.10.009_bb0085","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1158\/1078-0432.CCR-04-0220","article-title":"Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma","volume":"10","author":"Nielsen","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2012.10.009_bb0090","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF02967188","article-title":"Immunohistochemical analysis of GCDFP-15 and GCDFP-24 in mammary and non-mammary tissue","volume":"7","author":"Satoh","year":"2000","journal-title":"Breast Cancer"},{"key":"10.1016\/j.humpath.2012.10.009_bb0095","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.breast.2010.02.007","article-title":"Utility of mammaglobin and gross cystic disease fluid protein-15 (GCDFP-15) in confirming a breast origin for recurrent tumors","volume":"19","author":"Chia","year":"2010","journal-title":"Breast"},{"key":"10.1016\/j.humpath.2012.10.009_bb0100","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/dc.21039","article-title":"Diagnostic utility of mammaglobin and GCDFP-15 in the identification of metastatic breast carcinoma in fluid specimens","volume":"37","author":"Yan","year":"2009","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.humpath.2012.10.009_bb0105","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1186\/bcr587","article-title":"Elevated mammaglobin (h-MAM) expression in breast cancer is associated with clinical and biological features defining a less aggressive tumour phenotype","volume":"5","author":"Nunez-Villar","year":"2003","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.humpath.2012.10.009_bb0110","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1200\/JCO.2004.01.072","article-title":"Mammaglobin is associated with low-grade, steroid receptor-positive breast tumors from postmenopausal patients, and has independent prognostic value for relapse-free survival time","volume":"22","author":"Span","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2012.10.009_bb0115","first-page":"3028","article-title":"Mammaglobin expression in primary, metastatic, and occult breast cancer","volume":"59","author":"Watson","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2012.10.009_bb0120","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2559.2012.04253.x","article-title":"Cytokeratin 7: a re-evaluation of the \u2018tried and true\u2019 in triple-negative breast cancers","author":"Davion","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2012.10.009_bb0125","article-title":"GCDFP-15 and mammaglobin expression by immunohistochemistry is of limited utility in triple-negative breast cancer","author":"Huo","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2012.10.009_bb0130","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1309\/AJCP5W5SEZSEHUHE","article-title":"Metaplastic and medullary mammary carcinomas do not express mammaglobin","volume":"137","author":"Reyes","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2012.10.009_bb0135","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s12307-011-0085-4","article-title":"Partial mesenchymal to epithelial reverting transition in breast and prostate cancer metastases","volume":"5","author":"Chao","year":"2012","journal-title":"Cancer Microenviron"},{"key":"10.1016\/j.humpath.2012.10.009_bb0140","first-page":"6426","article-title":"Progression of cervical carcinomas is associated with down-regulation of CD9 but strong local re-expression at sites of transendothelial invasion","volume":"9","author":"Sauer","year":"2003","journal-title":"Clin Cancer Res"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817712003772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817712003772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T08:28:05Z","timestamp":1539937685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817712003772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0046817712003772"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2012.10.009","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}